My research activities involve initiating clinical trials in renal cancer and prostate cancer, and technology assessment as applied to the introduction of minimally invasive surgery.
Serum Adipokines as Predictors for the Outcome of Prostate Biopsies at Early Stage Prostate Cancer Diagnosis.
Cancer Manag Res. 2019;11:10043-10050
Am J Pathol. 2019 Dec;189(12):2366-2376
Can Urol Assoc J. 2019 Nov 05;:
J Urol. 2019 12;202(6):1165
Clin Biochem. 2019 Oct 28;:
CMAJ. 2019 Oct 28;191(43):E1177-E1178
Comparison of MRI- and TRUS-Informed Prostate Biopsy for Prostate Cancer Diagnosis in Biopsy-Naive Men: A Systematic Review and Meta-Analysis.
J Urol. 2019 Oct 14;:101097JU0000000000000595
Methylation markers in prostate biopsies are prognosticators for late biochemical recurrence and therapy after surgery in prostate cancer patients.
J Mol Diagn. 2019 Oct 09;:
2019 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guideline: Management of castration-resistant prostate cancer (CRPC).
Can Urol Assoc J. 2019 Oct;13(10):307-314
Stat Methods Med Res. 2019 Oct 11;:962280219880571
Clinician Investigator, Princess Margaret Cancer Centre
Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre
Assistant Professor, Departments of Surgery and Oncology, University of Toronto
Staff Surgeon, Surgical Oncology, Division of Urology, University Health Network